Literature DB >> 12785878

Experimental observation of four-photon entanglement from parametric down-conversion.

Manfred Eibl1, Sascha Gaertner, Mohamed Bourennane, Christian Kurtsiefer, Marek Zukowski, Harald Weinfurter.   

Abstract

We observe polarization entanglement between four photons produced from a single down-conversion source. The nonclassical correlations between the measurement results violate a generalized Bell inequality for four qubits. The characteristic properties and its easy generation with high interferometric contrast make the observed four-photon state well suited for implementing advanced quantum communication schemes such as multiparty quantum key distribution, secret sharing, and telecloning.

Year:  2003        PMID: 12785878     DOI: 10.1103/PhysRevLett.90.200403

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  4 in total

1.  Experimental generation of an eight-photon Greenberger-Horne-Zeilinger state.

Authors:  Yun-Feng Huang; Bi-Heng Liu; Liang Peng; Yu-Hu Li; Li Li; Chuan-Feng Li; Guang-Can Guo
Journal:  Nat Commun       Date:  2011-11-22       Impact factor: 14.919

2.  Three-photon bosonic coalescence in an integrated tritter.

Authors:  Nicolò Spagnolo; Chiara Vitelli; Lorenzo Aparo; Paolo Mataloni; Fabio Sciarrino; Andrea Crespi; Roberta Ramponi; Roberto Osellame
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  A solid state source of photon triplets based on quantum dot molecules.

Authors:  Milad Khoshnegar; Tobias Huber; Ana Predojević; Dan Dalacu; Maximilian Prilmüller; Jean Lapointe; Xiaohua Wu; Philippe Tamarat; Brahim Lounis; Philip Poole; Gregor Weihs; Hamed Majedi
Journal:  Nat Commun       Date:  2017-06-12       Impact factor: 14.919

4.  Tailoring entanglement through domain engineering in a lithium niobate waveguide.

Authors:  Yang Ming; Ai-Hong Tan; Zi-Jian Wu; Zhao-Xian Chen; Fei Xu; Yan-Qing Lu
Journal:  Sci Rep       Date:  2014-04-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.